☰

Access to antiretroviral drugs in low- and middle-income countries

This report examines global trends in ARV prices and assess how WHO treatment guidelines have influenced the uptake of different ARV formulations. It describes the current constraints limiting the use of second-line and third-line treatments and paediatric treatment, and it explores how the quality of ARVs can be secured and in-country distribution can be improved.

Management, Policy, Pricing, Procurement, Quality Assurance, Use

  • Sub-categories HIV/AIDS
  • Commodities Medicines
  • Latest update July 2014
  • Version July 2014
  • Developed by WHO
  • When to use This report examines global trends in ARV prices and assess how WHO treatment guidelines have influenced the uptake of different ARV formulations. It describes the current constraints limiting the use of second-line and third-line treatments and paediatric treatment, and it explores how the quality of ARVs can be secured and in-country distribution can be improved.
  • Languages English
  • Level of use Central
  • Form pdf file
  • Amount of training / TA required n/a
  • Inputs & outputs n/a
  • Cost free
  • Advantages n/a
  • Limitations n/a
  • Availability http://apps.who.int/iris/bitstream/10665/128150/1/9789241507547_eng.pdf?ua=1
  • Remarks
  • Contact amds@who.int (HIV/AIDS Department, World Health Organization)
  • Submission date 2014-07-28 14:22:27